Teralys Capital

Float offers modern financial services, powerful software and industry-leading support designed for every company and stage of growth. Our product suite includes corporate cards, bill pay, expense management and high-yield accounts, giving finance teams everything they need to manage spending and cash flow efficiently.

BKR Capital, established in 2021 and located in Toronto, Canada, is a venture capital firm dedicated to supporting early-stage black-led companies within the technology sector. Originally known as Black Innovation Capital, the firm focuses on investing in promising black founders, aiming to foster innovation and diversity in the tech industry. Through its investments, BKR Capital seeks to empower entrepreneurs and contribute to the growth of underrepresented communities in the business landscape.

Turnstone Biologics Inc. is a clinical-stage biotechnology company based in Ottawa, Canada, with an additional office in New York. Founded in 2015, the company is dedicated to advancing innovative viral immunotherapies aimed at improving cancer patient survival. Its lead product, RIVAL-01, utilizes a vaccinia virus backbone that encodes several immunomodulators, including Flt3 ligand, anti-CTLA-4 antibody, and IL-12 cytokine, which work together to enhance immune activity and optimize the tumor microenvironment for effective cancer treatment. Additionally, Turnstone Biologics is developing next-generation tumor-infiltrating lymphocyte (TIL) therapies by isolating and expanding the most potent and tumor-reactive T cells from patients' tumors, thereby harnessing the body's own immune system to combat solid tumors. Through these innovative approaches, Turnstone Biologics aims to deliver breakthrough cancer immunotherapies that significantly improve clinical outcomes for patients.

Verafin Inc. is a provider of cloud-based software solutions focused on fraud detection and anti-money laundering for financial institutions in North America. The company's flagship platform offers a comprehensive range of tools that enable banks and credit unions to identify potential money laundering or terrorist financing activities through advanced analytics and monitoring of customer transactions. With its capabilities in big data intelligence, visual storytelling, and collaborative investigations, Verafin helps institutions reduce false positive alerts and streamline compliance with regulations. The software also includes features for managing high-risk customers, vendor relationships, and reporting suspicious activities. Verafin is utilized by over 2,600 financial institutions and has established partnerships with various banking associations across the United States. Founded in 2003 and headquartered in Saint John's, Canada, Verafin continues to support financial institutions in their efforts to combat financial crime.

Busbud, Inc. offers an online platform for booking intercity bus travel, enabling users to search, compare, and purchase tickets across various destinations in Canada and internationally. Founded in 2011 and headquartered in Montreal, Canada, the company provides extensive travel information, including schedules, prices, reviews, and amenities, through its website and mobile application. Busbud aggregates bus schedules from over 10,463 cities in 89 countries, allowing travelers to plan their trips in multiple languages and currencies. The platform aims to simplify the travel experience by helping users find the best prices and options that suit their needs, while also providing customer support to enhance the booking experience.

Zymeworks Inc. is a clinical-stage biopharmaceutical company based in Vancouver, Canada, focused on the discovery, development, and commercialization of innovative biotherapeutics for cancer treatment. The company's lead candidates include ZW25, a bispecific antibody undergoing Phase I and II clinical trials for various tumors, including biliary tract and gastroesophageal adenocarcinomas, and ZW49, a bispecific antibody-drug conjugate in Phase I trials for advanced HER2-expressing cancers. Zymeworks employs a computational biotechnology approach, utilizing proprietary molecular modeling and simulation technologies to optimize therapeutic antibodies and other protein-based therapeutics. The company has established strategic partnerships with notable organizations such as Merck, Eli Lilly, and Bristol-Myers Squibb, as well as collaborations aimed at advancing antibody discovery and development. Founded in 2003, Zymeworks is dedicated to addressing unmet medical needs through its advanced therapeutic platforms and integrated drug development capabilities.